ARBEL IRIT 4
4 · BRAINSTORM CELL THERAPEUTICS INC. · Filed Aug 30, 2019
Insider Transaction Report
Form 4
ARBEL IRIT
Director
Transactions
- Exercise/Conversion
Common Stock
2019-08-28$2.25/sh+6,666$14,999→ 162,499 total - Exercise/Conversion
Common Stock
2019-08-28$2.25/sh+6,666$14,999→ 169,165 total - Sale
Common Stock
2019-08-28$3.67/sh−13,332$48,891→ 155,833 total - Exercise/Conversion
Stock Option (right to buy)
2019-08-28−6,666→ 0 totalExercise: $2.25From: 2009-12-13Exp: 2019-12-13→ Common Stock (6,666 underlying) - Exercise/Conversion
Stock Option (right to buy)
2019-08-28−6,666→ 0 totalExercise: $2.25From: 2010-08-31Exp: 2019-08-31→ Common Stock (6,666 underlying)
Footnotes (2)
- [F1]This is a weighted average price. These shares were sold in multiple transactions at prices ranging from $3.61 to $3.71, inclusive. The Reporting Person undertakes to provide to the Issuer, any securityholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- [F2]The option vested and became exercisable as to 33.3% of the number of shares subject to the option on each of August 31, 2010, August 31, 2011 and August 31, 2012.